Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

eVisit Closes $14 Million in Series a Funding Led by TVC Capital

SAAS Telehealth Company Dedicated to Simplifying Healthcare Delivery to Everyone, Everywhere, Any Time; Leading eVisit Virtual Care Platform Is Enabling Patient Care at More Than 100 Hospitals and Health Systems

eVisit, the leading SaaS telehealth company focused on enabling virtual care for hospitals and health systems, announced the completion of its $14 million Series A round led by TVC Capital, a software-focused growth equity fund, with participation from current investors Kickstart Seed Fund, University Growth Fund, and Jeremy Andrus.

The company also reported today that the eVisit Virtual Care platform is now serving more than 100 hospitals and health systems – including some of the largest healthcare enterprises in the U.S. – hosting hundreds of thousands of virtual visits and connecting providers and patients within the HIPAA-compliant eVisit platform enabling providers to deliver efficient and effective patient care.

Recommended AI News: BlueVoyant Announces Strategic Partnership With Argos Risk

“We are thrilled by the investment in eVisit by TVC, a renowned investor focused on mission-critical high-growth SaaS companies, as well as the continued support from Kickstart, Jeremy Andrus, and University Growth Fund,” said Bret Larsen, Co-Founder and CEO of eVisit.

Related Posts
1 of 28,988

“This funding will further eVisit’s rapid expansion within the telehealth industry by providing greater resources to our technology platform and customer care activities during this pivotal time for telehealth — in the ever-changing COVID-19 landscape and beyond.  In addition to scaling our organization with exceptional talent, we are planning to further enhance our marketing and sales outreach to support our focused go-to-market strategy. This new round is a testament to the collective confidence from these partners in our ability to power the virtual care strategies and execution for hospitals and health systems across North America.”

eVisit’s Virtual Care platform is unique among telehealth solutions with its flexible virtual workflows supporting all specialties and its end-to-end technology that fully virtualizes every step of the care process. This includes activities such as scheduling, intake and waiting room management, the virtual visit itself, and payment and discharge — all grounded in government-grade security, seamless EHR integration and leading analytics and reporting. As the only non-competing enterprise-wide virtual care platform, eVisit is partnering with the largest health systems and provider groups across the U.S. to accelerate their virtual care strategy and simplify healthcare delivery to everyone everywhere.

Recommended AI News: Mozambique Pins Hope on Germany to Revive Gas Industry Opportunities in 2020-21

Steve Hamerslag, Managing Partner of TVC Capital said, “We are very pleased to have the opportunity to work with this amazing team at eVisit. The telehealth market is exploding with rapid provider and end user adoption of this critical capability. We were extremely impressed with the depth of this enterprise-class service offering, which was validated by the breadth of adoption by their large and sophisticated customer base.  eVisit has an early seat in this expanding market, and we are thrilled to be a part of a journey of helping to improve patient outcomes, while reducing cost.”

Recommended AI News: Luminoso Expands Product Leadership with Two New Hires

Leave A Reply

Your email address will not be published.